Non-myeloablative allogeneic hematopoietic stem cell transplantation.
Shelburne N, Bevans M.
Semin Oncol Nurs. 2009 May;25(2):120-8. doi: 10.1016/j.soncn.2009.03.006.
Non-myeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders; past accomplishments and future goals.
Slavin S, Aker M, Shapira MY, Panigrahi S, Gabriel C, Or R.
Transfus Apher Sci. 2002 Oct;27(2):159-66. doi: 10.1016/s1473-0502(02)00038-1.
Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group.
Geisler CH, Kolstad A, Laurell A, Andersen NS, Pedersen LB, Jerkeman M, Eriksson M, Nordström M, Kimby E, Boesen AM, Kuittinen O, Lauritzsen GF, Nilsson-Ehle H, Ralfkiaer E, Akerman M, Ehinger M, Sundström C, Langholm R, Delabie J, Karjalainen-Lindsberg ML, Brown P, Elonen E; Nordic Lymphoma Group.
Blood. 2008 Oct 1;112(7):2687-93. doi: 10.1182/blood-2008-03-147025. Epub 2008 Jul 14.
Critical review on non-myeloablative stem cell transplantation (NST).
Anagnostopoulos A, Giralt S.
Crit Rev Oncol Hematol. 2002 Nov;44(2):175-90. doi: 10.1016/s1040-8428(01)00226-8.
Update on non-myeloablative stem cell transplantation for hematologic malignancies.
Giralt S.
Int J Hematol. 2002 Aug;76 Suppl 1:176-83. doi: 10.1007/BF03165241.
Update on non-myeloablative stem cell transplantation for hematologic malignancies.
Giralt S.
Int J Hematol. 2002 Aug;76 Suppl 1:368-75.
Maternal-fetal relationship, natural chimerism and bilateral transplantation tolerance as the basis for non-myeloablative stem cell transplantation.
Slavin S.
Int J Hematol. 2002 Aug;76 Suppl 1:172-5. doi: 10.1007/BF03165240.
Overview of autologous stem cell transplantation.
Saba N, Abraham R, Keating A.
Crit Rev Oncol Hematol. 2000 Oct;36(1):27-48. doi: 10.1016/s1040-8428(00)00087-1.
Stem-cell transplantation in non-Hodgkin's lymphoma: improving outcome.
Gianni AM, Berinstein NL, Evans PA, López-Guillermo A, Solano C.
Anticancer Drugs. 2002 Nov;13 Suppl 2:S35-42. doi: 10.1097/00001813-200211002-00006.
Stem cell isolation.
Shpall EJ, Gee A, Cagnoni PJ, Hogan C, Gehling U, Hami L, Franklin W, Bearman SI, Ross M, Jones RB.
Curr Opin Hematol. 1995 Nov;2(6):452-9. doi: 10.1097/00062752-199502060-00009.
